Heide Fettke's PhD confirmation, "Circulating tumour DNA: identifying markers of therapeutic resistance and response in advanced prostate cancer", 20 March

All staff and students are invited to Heide Fettke's PhD confirmation.

20 March, 11am, Seminar room 3, TRF level 2

Synopsis:  The last several years has seen the approval of multiple new therapies for advanced prostate cancer that target the androgen receptor (AR) axis. Despite improvements in clinical outcomes, resistance to these agents is inevitable. This project aims to design and implement a highly sensitive next-generation sequencing assay capable of identifying prostate-cancer associated mutations in patient circulating tumour DNA (ctDNA) in order to understand therapeutic response and resistance.

Supervisors: A/Prof Arun Azad, Prof Melissa Southey